| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 151 |
| 1 | PREDNISOLONE ORAL | 151 |
| 2 | PREDNISOLONE ORAL SOLUTION | 151 |
| 3 | TACROLIMUS | 133 |
| 4 | METHYLPREDNISOLONE | 89 |
| 5 | MYCOPHENOLATE MOFETIL | 85 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 85 |
| 7 | RITUXIMAB | 85 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 83 |
| 9 | TACROLIMUS OINTMENT 0.1% | 83 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 1 | 0.0139 |
| 1 | EPCORITAMAB-BYSP | 9 | 0.0067 |
| 2 | FOSCARNET SODIUM | 26 | 0.0065 |
| 3 | FLUCYTOSINE | 8 | 0.0056 |
| 4 | BENDAMUSTINE HYDROCHLORIDE | 46 | 0.0054 |
| 5 | ELRANATAMAB-BCMM | 6 | 0.0052 |
| 6 | MOGAMULIZUMAB-KPKC | 7 | 0.0051 |
| 7 | GANCICLOVIR SODIUM | 53 | 0.0050 |
| 8 | LETERMOVIR | 15 | 0.0046 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 38 | 0.0045 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 8 | 0.0056 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 7 | 0.0051 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 15 | 0.0046 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 19 | 0.0032 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 72 | 0.0032 |
| 5 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 9 | 0.0022 |
| 6 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 7 | Echinocandin Antifungal [EPC] | 17 | 0.0021 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 16 | 0.0012 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 92 | 0.0009 |